Study on Differential Diagnostic Ability of Colonoscopy Diagnostic Software EndoBRAIN-X in JNET type1 Lesions

Study on Differential Diagnostic Ability of Colonoscopy Diagnostic Software EndoBRAIN-X in JNET type1 Lesions - EndoBRAIN challenge study X1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054752

Enrollment

100

Registered

2024-06-25

Start date

2024-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal serrated lesions

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 20 years of age or older undergoing colonoscopy with JNET Type 1 lesions of 6 mm or greater.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of surgery involving colorectal resection other than appendicectomy 2. Patients with concomitant inflammatory bowel disease; ulcerative colitis, Crohn's disease, etc 3. Patients with six or more JNET Type 1 lesions measuring at least 6 mm or complicated with polyposis coli or hereditary non-polyposis colorectal cancer 4. Patients taking antiplatelet or anticoagulant drugs 5. Pregnant, lactating, or possibly pregnant at the time of examination 6. Patients with other more serious concurrent illnesses, etc., for which the physician in charge determines that the patient is not suitable for the procedure.

Design outcomes

Primary

Measure	Time frame
Differential diagnostic performance of EndoBRAIN-X in JNET Type 1 lesions >6 mm (accuracy, sensitivity, specificity, positive predictive value, negative predictive value)	—

Secondary

Measure	Time frame
Stability of EndoBRAIN-X determination results and rate of agreement with expert's diagnosis	—

Countries

Japan

Contacts

Public ContactDaizen Hirata

Sano hospital Gastrointestinal Center, & Institute of Minimally-Invasive Endoscopic Care

daizenhirata@gmail.com078-785-1000

Outcome results